n,n-dimethyltryptamine has been researched along with Injury, Ischemia-Reperfusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bidiga, L; Deak, A; Frecska, E; Ghanem, S; Magyar, Z; Mester, A; Nemes, B; Nemeth, N; Peto, K; Somogyi, V; Tanczos, B | 1 |
| Bidiga, L; Deák, Á; Frecska, E; Ghanem, S; Kállay, M; Magyar, Z; Mester, A; Nemes, B; Németh, N; Pető, K; Sógor, V; Tánczos, B | 1 |
2 other study(ies) available for n,n-dimethyltryptamine and Injury, Ischemia-Reperfusion
| Article | Year |
|---|---|
Hemorheological and metabolic consequences of renal ischemia-reperfusion and their modulation by N,N-dimethyl-tryptamine on a rat model.
Topics: Animals; Disease Models, Animal; Erythrocyte Deformability; Kidney Diseases; Male; N,N-Dimethyltryptamine; Rats; Reperfusion Injury; Rheology | 2018 |
N,N-dimethyltryptamine Prevents Renal Ischemia-Reperfusion Injury in a Rat Model.
Topics: Animals; Antioxidants; Disease Models, Animal; Kidney; Kidney Transplantation; Male; N,N-Dimethyltryptamine; Rats; Receptors, sigma; Reperfusion Injury; Sigma-1 Receptor | 2019 |